LncRNA MIAT downregulates IL-1β, TNF-ɑ to suppress macrophage inflammation but is suppressed by ATP-induced NLRP3 inflammasome activation

References

• Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094–1108.
   PubMed Web of Science ®Google Scholar
• Gerlag DM, Raza K, van Baarsen LG, et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the study group for risk factors for rheumatoid arthritis. Ann Rheum Dis. 2012;71(5):638–641.
   PubMed Web of Science ®Google Scholar
• Nomeir AM, Turner R, Watts E, et al. Cardiac involvement in rheumatoid arthritis. Ann Intern Med. 1973;79(6):800–806.
   PubMed Web of Science ®Google Scholar
• Liao KP. Cardiovascular disease in patients with rheumatoid arthritis. Trends Cardiovasc Med. 2017;27(2):136–140.
   PubMed Web of Science ®Google Scholar
• Mavrogeni S, Dimitroulas T, Sfikakis PP, et al. Heart involvement in rheumatoid arthritis: multimodality imaging and the emerging role of cardiac magnetic resonance. Semin Arthritis Rheum. 2013;43(3):314–324.
   PubMed Web of Science ®Google Scholar
• England BR, Thiele GM, Anderson DR, et al. Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. BMJ. 2018;361:k1036.
   PubMed Web of Science ®Google Scholar
• Khan F. Assessment of endothelial function as a marker of cardiovascular risk in patients with rheumatoid arthritis. Int J Rheum Dis. 2010;13(3):189–195.
   PubMed Web of Science ®Google Scholar
• Lazúrová I, Tomáš Ľ. Cardiac impairment in rheumatoid arthritis and influence of Anti-TNFα treatment. Clin Rev Allergy Immunol. 2017;52(3):323–332.
   PubMed Web of Science ®Google Scholar
• Siouti E, Andreakos EJBP. The many facets of macrophages in rheumatoid arthritis. Biochem Pharmacol. 2019;165:152–169.
   Google Scholar
• Udalova IA, Mantovani A, Feldmann M. Macrophage heterogeneity in the context of rheumatoid arthritis. Nat Rev Rheumatol. 2016;12(8):472–485.
   PubMed Web of Science ®Google Scholar
• Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140(6):821–832.
   PubMed Web of Science ®Google Scholar
• Jianhui L, Rosenblatt-Velin N, Loukili N, et al. Endotoxin impairs cardiac hemodynamics by affecting loading conditions but not by reducing cardiac inotropism. Am J Physiol Heart Circ Physiol. 2010;299(2):H492–501.
   PubMed Web of Science ®Google Scholar
• House LM, Morris RT, Barnes TM, et al. Tissue inflammation and nitric oxide-mediated alterations in cardiovascular function are major determinants of endotoxin-induced insulin resistance. Cardiovasc Diabetol. 2015;14(1):56.
   PubMed Web of Science ®Google Scholar
• Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477–489.
   PubMed Web of Science ®Google Scholar
• Rada B, Park JJ, Sil P, et al. NLRP3 inflammasome activation and interleukin-1β release in macrophages require calcium but are independent of calcium-activated NADPH oxidases. Inflammation Res. 2014;63(10):821–830.
   PubMed Web of Science ®Google Scholar
• He Y, Hara H, Núñez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci. 2016;41(12):1012–1021.
   PubMed Web of Science ®Google Scholar
• Shen HH, Yang YX, Meng X, et al. NLRP3: A promising therapeutic target for autoimmune diseases. Autoimmun Rev. 2018;17(7):694–702.
   PubMed Web of Science ®Google Scholar
• Mathews RJ, Robinson JI, Battellino M, et al. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Ann Rheum Dis. 2014;73(6):1202–1210.
   PubMed Web of Science ®Google Scholar
• Liu D, Zeng X, Li X, et al. Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases. Basic Res Cardiol. 2018;113(1):5.
   PubMed Web of Science ®Google Scholar
• Sun Q, Hao Q, Prasanth KV. Nuclear long noncoding RNAs: key regulators of gene expression. Trends Genet. 2018;34(2):142–157.
   PubMed Web of Science ®Google Scholar
• Boon RA, Jaé N, Holdt L, et al. Long Noncoding RNAs: from Clinical Genetics to Therapeutic Targets? J Am Coll Cardiol. 2016;67(10):1214–1226.
   PubMed Web of Science ®Google Scholar
• Xu F, Jin L, Jin Y, et al. Long noncoding RNAs in autoimmune diseases. J Biomed Mater Res A. 2019;107(2):468–475.
   PubMed Web of Science ®Google Scholar
• Li Z, Li X, Jiang C, et al. Long non-coding RNAs in rheumatoid arthritis. Cell Prolif. 2018;51(1). DOI:10.1111/cpr.12404
   Web of Science ®Google Scholar
• Yuan M, Wang S, Yu L, et al. Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease activity in PBMCs from patients with rheumatoid arthritis. PloS One. 2017;12(11):e0186795.
   PubMed Web of Science ®Google Scholar
• Sun C, Huang L, Li Z, et al. Long non-coding RNA MIAT in development and disease: a new player in an old game. J Biomed Sci. 2018;25(1):23.
   PubMed Web of Science ®Google Scholar
• Qu X, Du Y, Shu Y, et al. MIAT is a pro-fibrotic long non-coding RNA governing cardiac fibrosis in post-infarct myocardium. Sci Rep. 2017;7(1):42657.
   PubMed Web of Science ®Google Scholar
• Yu B, Wang S. Angio-LncRs: lncRNAs that regulate angiogenesis and vascular disease. Theranostics. 2018;8(13):3654–3675.
   PubMed Web of Science ®Google Scholar
• Augello A, Tasso R, Negrini SM, et al. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheumatism. 2007;56(4):1175–1186.
   PubMed Web of Science ®Google Scholar
• Hirano S, Zhou Q, Furuyama A, et al. Differential regulation of IL-1β and IL-6 release in murine macrophages. Inflammation. 2017;40(6):1933–1943.
   PubMed Web of Science ®Google Scholar
• Tu J, Hong W, Guo Y, et al. Ontogeny of synovial macrophages and the roles of synovial macrophages from different origins in arthritis. Front Immunol. 2019;10:1146.
   PubMed Web of Science ®Google Scholar
• Kurowska-Stolarska M, Alivernini S. Synovial tissue macrophages: friend or foe? RMD Open. 2017;3(2):e000527.
   PubMed Web of Science ®Google Scholar
• Nicolás-Ávila JA, Hidalgo A, Ballesteros I. Specialized functions of resident macrophages in brain and heart. J Leukoc Biol. 2018;104(4):743–756.
   PubMed Web of Science ®Google Scholar
• Fu XL, Duan W, Su CY, et al. Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression. Cancer Immunol Immunother. 2017;66(12):1597–1608.
   PubMed Web of Science ®Google Scholar
• Dubey A, Izakelian L, Ayaub EA, et al. Separate roles of IL-6 and oncostatin M in mouse macrophage polarization in vitro and in vivo. Immunol Cell Biol. 2018;96(3):257–272.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zheng Y, Li H. NLRP3 inflammasome plays an important role in the pathogenesis of collagen-induced arthritis. Mediators Inflamm. 2016;(2016):9656270.
   PubMed Web of Science ®Google Scholar
• Zhao C, Gu Y, Zeng X, et al. NLRP3 inflammasome regulates th17 differentiation in rheumatoid arthritis. Clin Immunol. 2018;197:154–160.
   PubMed Web of Science ®Google Scholar
• An N, Gao Y, Si Z, et al. Regulatory mechanisms of the NLRP3 inflammasome, a novel immune-inflammatory marker in cardiovascular diseases. Front Immunol. 2019;10:1592.
   PubMed Web of Science ®Google Scholar
• Lima Jr. H, Jacobson LS, Goldberg MF, et al. Role of lysosome rupture in controlling NLRp3 signaling and necrotic cell death. Cell Cycle. 2013;12(12):1868–1878.
   PubMed Web of Science ®Google Scholar
• Yin J, Wang Y, Hu H, et al. P2X receptor inhibition attenuated sympathetic nerve sprouting after myocardial infarction via the NLRP3/IL-1β pathway. J Cell Mol Med. 2017;21(11):2695–2710.
   PubMed Web of Science ®Google Scholar
• Liao J, He Q, Li M, et al. LncRNA MIAT: myocardial infarction associated and more. Gene. 2016;578(2):158–161.
   PubMed Web of Science ®Google Scholar